Novartis International AG
Lichtstrasse 35
Basel
CH-4056
United States
Tel: 41-61-324-1111
Fax: 41-61-324-8001
Website: http://www.novartis.com/
57 articles about Novartis International AG
-
Global Pharmaceutical Company Appoints CBRE to Deliver Integrated Real Estate Management and Consulting Services Around the World
10/29/2019
CBRE will support Novartis in the transformation of its real estate portfolio, improving its employee workplace experience and driving its sustainability agenda.
-
Novartis International AG Presents Key Advances In Cancer Research At American Society of Clinical Oncology And European Hematology Association From Four New Pivotal Studies In Lung, Blood And Skin Cancers
5/22/2014
-
Novartis International AG (JOBS) to Invest $1 Billion in China
11/3/2009
-
Novartis International AG Says on Track to Deliver US Vaccine Order
10/29/2009
-
Novartis International AG Says EU Approves Inflammatory Disease Drug
10/28/2009
-
Novartis International AG Says Glivec Has Potential to Treat PAH; Drug Did Not Reach Statistical Significance In Main Target
10/8/2008
-
MorphoSys AG to Host Conference Call to Discuss New Strategic Alliance With Novartis
12/3/2007
-
CIBA Vision Corporation, the Eye Care Unit of Novartis International AG, Announces Settlement of Patent Litigation with CooperVision, Inc.
11/21/2007
-
Novartis International AG Proposes Changes to Galvus Prescribing
11/6/2007
-
New Safety Issues to Delay Novartis International AG's Galvus
11/6/2007
-
Novartis International AG Says U.S. Approves Tasigna Cancer Drug
10/30/2007
-
Novartis International AG to Strengthen Biotech, Health Consumer Divisions - CEO
10/22/2007
-
Novartis International AG to Cut 1260 Positions, Announces Management Changes
10/18/2007
-
Novartis International AG Delivers Record Earnings in First Nine Mmonths of 2007
10/18/2007
-
Novartis International AG Says Osteoporosis Drug Approved in Europe
10/5/2007
-
Teva Pharmaceutical Industries Limited Announces Court of Appeals Denies Novartis International AG's Emergency Motion on Generic Famvir(R)
10/1/2007
-
Novartis International AG Invests $65 Million to Develop Manufacturing
9/28/2007
-
Novartis International AG Diabetes Drug Galvus Approved in Europe
9/28/2007
-
Novartis International AG Painkiller Prexige Gets "Not Approvable" Letter in U.S.
9/27/2007
-
Novartis International AG CEO Pours Cold Water Over M&A Talk -Paper
9/17/2007